题名 | FGF10 ameliorates lipopolysaccharide-induced acute lung injury in mice via the BMP4-autophagy pathway |
作者 | |
发表日期 | 2022-12-22 |
发表期刊 | Frontiers in pharmacology 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Journal Article |
关键词 | AECs BMP4 FGF10 acute lung injury autophagy |
其他关键词 | GROWTH-FACTOR ; AUTOPHAGY ; INFLAMMATION ; MECHANISMS ; MITOPHAGY ; CELLS ; BMP4 |
摘要 | Introduction: Damage to alveolar epithelial cells caused by uncontrolled inflammation is considered to be the main pathophysiological change in acute lung injury. FGF10 plays an important role as a fibroblast growth factor in lung development and lung diseases, but its protective effect against acute lung injury is unclear. Therefore, this study aimed to investigate protective effect and mechanism of FGF10 on acute lung injury in mice. Methods: ALI was induced by intratracheal injection of LPS into 57BL/6J mice. Six hours later, lung bronchoalveolar lavage fluid (BALF) was acquired to analyse cells, protein and the determination of pro-inflammatory factor levels, and lung issues were collected for histologic examination and wet/dry (W/D) weight ratio analysis and blot analysis of protein expression. Results: We found that FGF10 can prevent the release of IL-6, TNF-α, and IL-1β, increase the expression of BMP4 and autophagy pathway, promote the regeneration of alveolar epithelial type Ⅱ cells, and improve acute lung injury. BMP4 gene knockdown decreased the protective effect of FGF10 on the lung tissue of mice. However, the activation of autophagy was reduced after BMP4 inhibition by Noggin. Additionally, the inhibition of autophagy by 3-MA also lowered the protective effect of FGF10 on alveolar epithelial cells induced by LPS. Conclusions: These data suggest that the protective effect of FGF10 is related to the activation of autophagy and regeneration of alveolar epithelial cells in an LPS-induced ALI model, and that the activation of autophagy may depend on the increase in BMP4 expression |
资助项目 | New Drug Research and Development in the Major National Science and Technology Projects of China[2020ZX09201002];Wenzhou science and technology innovation project[ZY2020026];Ningbo Natural Science Foundation of China[2021J032,2022J043];National Science Foundation of China[81772450,81973382]; |
出版者 | FRONTIERS MEDIA SA |
ISSN | 1663-9812 |
EISSN | 1663-9812 |
卷号 | 13 |
DOI | 10.3389/fphar.2022.1019755 |
页数 | 13 |
WOS类目 | Pharmacology & Pharmacy |
WOS研究方向 | Pharmacology & Pharmacy |
WOS记录号 | WOS:000944087400001 |
收录类别 | PUBMED ; SCIE ; SCOPUS |
URL | 查看原文 |
PubMed ID | 36618911 |
SCOPUSEID | 2-s2.0-85145577792 |
通讯作者地址 | [Zhang, Hailin]Department of Children’s Respiration,The Second Affiliated Hospital & Yuying Children’s Hospital,Wenzhou Medical University,Zhejiang,Wenzhou,China ; [Zhang, Hongyu]Department of Pharmacy,Zhuji People’s Hospital,The Affiliated Hospital of Wenzhou Medical University,Zhejiang,Shaoxing,China |
Scopus学科分类 | Pharmacology;Pharmacology (medical) |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/172708 |
专题 | 基础医学院(机能实验教学中心) 药学院(分析测试中心) 附属第二医院 第二临床医学院、附属第二医院、育英儿童医院 其他_附属诸暨医院(诸暨市人民医院) 其他_附属苍南医院(苍南县人民医院) 其他_温州医科大学慈溪生物医药研究院 |
通讯作者 | Zhang, Hongyu; Zhang, Hailin |
作者单位 | 1.School of Basic Medical Sciences,Institute of Hypoxia Research,Wenzhou Medical University,Zhejiang,Wenzhou,China; 2.Department of Children’s Respiration,The Second Affiliated Hospital & Yuying Children’s Hospital,Wenzhou Medical University,Zhejiang,Wenzhou,China; 3.Department of Ultrasound,Children’s Hospital,School of Medicine,Zhejiang University,Zhejiang,Hangzhou,China; 4.Department of Nephrology,Affiliated Cangnan Hospital,Wenzhou Medical University,Cangnan, Zhejiang,China; 5.Department of Pharmacy,Zhuji People’s Hospital,The Affiliated Hospital of Wenzhou Medical University,Zhejiang,Shaoxing,China; 6.School of Pharmaceutical Sciences,Cixi Biomedical Research Institute,Wenzhou Medical University,Zhejiang,Wenzhou,China |
第一作者单位 | 基础医学院(机能实验教学中心); 附属第二医院 |
通讯作者单位 | 附属第二医院; 温州医科大学 |
第一作者的第一单位 | 基础医学院(机能实验教学中心) |
推荐引用方式 GB/T 7714 | Kong, Xiaoxia,Lu, Liling,Lin, Daopeng,et al. FGF10 ameliorates lipopolysaccharide-induced acute lung injury in mice via the BMP4-autophagy pathway[J]. Frontiers in pharmacology,2022,13. |
APA | Kong, Xiaoxia., Lu, Liling., Lin, Daopeng., Chong, Lei., Wen, Shunhang., ... & Zhang, Hailin. (2022). FGF10 ameliorates lipopolysaccharide-induced acute lung injury in mice via the BMP4-autophagy pathway. Frontiers in pharmacology, 13. |
MLA | Kong, Xiaoxia,et al."FGF10 ameliorates lipopolysaccharide-induced acute lung injury in mice via the BMP4-autophagy pathway".Frontiers in pharmacology 13(2022). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论